Functional antagonism between endogenous neuropeptide Y and calcitonin gene-related peptide in mesenteric resistance arteries

Journal of Pharmacology and Experimental Therapeutics

Volumn 324, Issue 3, 2008, Pages 930-937

  De Mey, Jo G R ^a,b   Megens, Remco ^a   Fazzi, Gregorio E ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CAPSAICIN; NALPHA (DIPHENYLACETYL) N (4 HYDROXYBENZYL) DEXTRO ARGININAMIDE; NEUROPEPTIDE RECEPTOR; NEUROPEPTIDE Y; OLCEGEPANT; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG INHIBITION; ELECTRIC FIELD; ELECTROSTIMULATION; MALE; MESENTERIC ARTERY; MOUSE; MUSCLE CONTRACTION; MUSCLE EXCITATION; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RESISTANCE BLOOD VESSEL; SMOOTH MUSCLE FIBER; VASODILATATION;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MESENTERIC ARTERIES; MICE; MICE, INBRED C57BL; NEUROPEPTIDE Y; RATS; RATS, WISTAR; VASOCONSTRICTION; VASOMOTOR SYSTEM;

EID: 40849083802     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.107.133660     Document Type: Article

References (33)

1. Aakerlund L, Gether U, Fuhlendorff J, Schwartz TW, and Thastrup O (1990) Y1 receptors for neuropeptide Y are coupled to mobilization of intracellular calcium and inhibition of adenylate cyclase. FEBS Lett 260:73-78.
2. Bevan JA (1983) The human adrenergic neurovascular mechanism. Gen Pharmacol 14:21-26.
3. Brain SD and Grant AD (2004) Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev 84:903-934.
4. Burnstock G (2004) Cotransmission. Curr Opin Pharmacol 4:47-52.
5. Carmeliet P and Tessier-Lavigne M (2005) Common mechanisms of nerve and blood vessel wiring. Nature 436:193-200.
6. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, and Julius D (1997) The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389:816-824.
7. Chauhan M, Gangulla PRR, Wimalawansa SJ, and Yallampalli C (2004) Studies of the effects of the N-terminal domain antibodies of calcitonin receptor-like receptor and receptor-activity modifying protein 1 on calcitonin gene-related peptide-induced vasorelaxation in rat uterine artery. Biol Reprod 70:1658-1663.
8. Cottrell GS, Roosterman D, Marvizon J-C, Song B, Wick E, Pikos S, Wong H, Berthelier C, Tang Y, Stemini C, et al. (2005) Localization of calcitonin receptor-like receptor and receptor activity modifying protein 1 in enteric neurons, dorsal root ganglia, and the spinal cord of the rat. J Comp Neurol 490:239-255.
9. Deng PY and Li YJ (2005) Calcitonin gene-related peptide and hypertension. Peptides 26:1676-1685.
10. Doods H. Hallermayer G, Wu D, Entzeroth M, Rudolf K, Engel W, and Eberlein W (2000) Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. Br J Pharmacol 129:420-423.
11. Doods HN, Wieland H, Engel W, Eberlein W, Willim K-D, Entzeroth M, Wienen W, and Rudolf K (1996) BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: a review of its pharmacological properties. Regul Pept 65:71-77.
12. Dubinion JH, Zaichuan MI, and Jackson EK (2006) Role of renal sympathetic nerves in regulating renovascular responses to angiotensin II in spontaneously hypertensive rats. J Pharmacol Exp Ther 317:1330-1336.
13. Fernandez-Patron C, Stewart KG, Zhang Y, Koivunen E, Radomski MW, and Davidge ST (2000) Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction. Circ Res 13:670-676.
14. Glebova NO and Ginty DD (2005) Growth and survival signals controlling sympathetic nervous system development. Annu Rev Neurosci 28:191-222.
15. Gradin KA, Li J-Y, Andersson O, and Simonsen U (2003) Enhanced neuropeptide Y immunoreactivity and vasoconstriction in mesenteric small arteries from spontaneously hypertensive rats. J Vasc Res 40:252-265.
16. Hatanaka Y, Hobar N, Honghua J, Akiyama S, Nawa H, Kobayashi Y, Takayama E, Gomita Y, and Kawasaki H (2006) Neuronal nitric-oxide synthase inhibition facilitates adrenergic neurotransmission in rat mesenteric resistance arteries. J Pharmacol Exp Ther 316:490-497.
17. Huang Y and Wang DH (2001) Role of rennin-angiotensin-aldosterone system in salt-sensitive hypertension induced by sensory denervation. Am J Physiol Heart Circ Physiol 281:H2143-H2149.
18. Kawasaki H, Nuki C, Saito A, and Takasaki K (1991) NPY modulates neurotransmission of CGRP-containing vasodilator nerves in rat mesenteric arteries. Am J Physiol Heart Circ Physiol 261:H683-H690.
19. Kawasaki H, Okazaki M, Nakatsuma A, Mimaki Y, Araki H, and Gomita Y (1999) Long-term treatment with angiotensin converting enzyme inhibitor restores reduced calcitonin gene-related peptide containing vasodilator nerve function in mesenteric artery of spontaneously hypertensive rats. Jpn J Pharmacol 79:221-229.
20. Luff SE, Young SB, and Maclachlam EM (2005) Hyperinnervation of mesenteric arteries of spontaneously hypertensive rats by sympathetic but not primary afferent axons: an ultrastructural analysis. J Vasc Res 42:348-358.
21. Márquez-Rodas I, Longo F, Rothin RP, and Balfagon G (2006) Pathophysiology and therapeutic possibilities of calcitonin gene-related peptide in hypertension. J Physiol Biochem 62:45-56.
22. Megens RT, Reitsema S, Schiffers PH, Hilgers RH, De Mey JGR, Slaaf DW, oude Egbrink MG, and van Zandvoort MA (2007) Two-photon microscopy of vital murine elastic and muscular arteries: combined structural and functional imaging with subcellular resolution. J Vasc Res 44:87-89.
23. Michel MC (1998) International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev 50:143-150.
24. Stassen FR, Raat NJ, Brouwers-Ceiler DL, Fazzi GE, Smits JFM, and De Mey JGR (1997) Angiotensin II induces media hypertrophy and hyperreactivity in mesenteric but not epigastric small arteries of the rat. J Vasc Res 34:289-297.
25. Supowit SC, Rao A, Bowers MC, Zhao H, Fink G, Steficek B, Patel P, Katki KA, and Dipette DJ (2005) Calcitonin gene-related peptide protects against hypertension-induced heart and kidney damage. Hypertension 45:109-114.
26. Szallasi A and Blumberg PM (1999) Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 51:159-212.
27. Thakor AS and Giussani DA (2005) Role of nitric oxide in mediating in vivo vascular responses to calcitonin gene-related peptide in essential and peripheral circulations in the fetus. Circulation 112:2510-2516.
28. Vonend O, Okonek A, Stegbauer J, Habbel S, Quack I, and Rump LC (2005) Renovascular effects of sympathetic cotransmitters ATP and NPY are age-dependent in spontaneously hypertensive rats. Cardiovasc Res 66:345-352.
29. Wang DH, Li J, and Qiu J (1998) Salt-sensitive hypertension induced by sensorydenervation. Hypertension 32:649-653.
30. Wang Y and Wang DH (2004) Prevention of endothelin-1-induced increases in blood pressure: role of endogenous CGRP. Am J Physiol Heart Circ Physiol 287:H1868-H1874.
31. Yallampalli C, Chauhan M, Thota CS, Kondapaka S, and Wimalawansa SJ (2002) Calcitonin gene-related peptide in pregnancy and its emerging receptor heterogeneity. Trends Endocrinol Metab 13:263-269.
32. Zhang Z, Dickerson IM, and Russo AF (2006) Calcitonin gene-related peptide receptor activation by receptor activity modifying protein-1 gene transfer to vascular smooth muscle cells. Endocrinology 147:1932-1940.
33. Zhao X-H, Sun XY, Edvinsson L, and Hedner T (1997) Does the neuropeptide Y Y1 receptor contribute to blood pressure control in the spontaneously hypertensive rat? J Hypertens 15:19-27.